ExperTox Unknown Drug Panel: How It Works | AMH Nationwide
How the ExperTox Unknown Drug Panel Works for Reliable Drug Detection
The ExperTox Unknown Drug Panel how it works involves a precise process starting with sample collection at certified sites, followed by expert lab screening and confirmation testing, and concluding with a certified Medical Review Officer review. This ensures accurate identification of unknown substances in a sample. Call (877) 731-6362.
How is the sample collected for the ExperTox Unknown Drug Panel?
The sample collection for the ExperTox Unknown Drug Panel begins at one of the nationwide collection sites affiliated with five national lab networks: Quest Diagnostics, LabCorp, Omega Labs, United States Drug Testing Labs, and ExperTox. AMH Nationwide directs the requester to the appropriate collection site.
Collection typically involves providing a urine specimen, which is the standard matrix for this panel. The collection process follows strict chain-of-custody protocols to maintain sample integrity and prevent tampering.
What happens during lab analysis of the ExperTox Unknown Drug Panel?
Once collected, the specimen is sent to the ExperTox laboratory for analysis. The lab performs an initial immunoassay screening designed to detect a wide range of known and unknown substances in the urine.
If the screening identifies any positive or inconclusive results, the sample undergoes confirmatory testing using advanced methods such as gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). These confirmatory tests provide precise identification and quantification of the substances present.
How do screening and confirmation work together in this panel?
The ExperTox Unknown Drug Panel uses a two-step process to ensure accurate results. The initial screening quickly identifies potential drug presence but may not specify exact substances.
Confirmatory testing follows for any non-negative screens. This step verifies the initial findings with high specificity, ruling out false positives and detecting substances that might not be identified by screening alone.
What role does the Medical Review Officer play in the process?
Every non-negative screen in the ExperTox Unknown Drug Panel is reviewed by a certified Medical Review Officer (MRO). The MRO evaluates the lab results in the context of the donor’s medical history and any prescription information provided.
This review ensures that legitimate medical explanations are considered before finalizing the results, maintaining fairness and accuracy in reporting.
Need the ExperTox Unknown Drug Panel?
Contact AMH Nationwide to schedule your sample collection at a certified site. Call (877) 731-6362 for guidance and next steps.
What is the end-to-end process of the ExperTox Unknown Drug Panel?
The process starts with AMH Nationwide directing the requester to a certified collection site affiliated with one of five national lab networks. After urine collection under chain-of-custody protocols, the sample is sent to the ExperTox lab for screening.
Positive or inconclusive screens then undergo confirmatory testing. Following lab analysis, a certified Medical Review Officer reviews any non-negative results to provide a final, verified report.
| Step | Description |
|---|---|
| 1. Collection | Sample collected at certified site under chain-of-custody |
| 2. Screening | Immunoassay screening to detect substances |
| 3. Confirmation | GC-MS or LC-MS/MS confirmatory testing on positives |
| 4. MRO Review | Certified Medical Review Officer evaluates results |
| 5. Reporting | Final verified results provided to requester |
What substances can the ExperTox Unknown Drug Panel detect?
The ExperTox Unknown Drug Panel is designed to detect a broad spectrum of drug compounds, including both common and uncommon substances. The unknown drug panel focuses on identifying substances that may not be included in standard drug panels, providing comprehensive detection.
Because the panel targets unknown or unexpected substances, it is often used when there is a need to identify drugs not typically screened for in routine tests.
Common Questions
No, AMH Nationwide does not offer online ordering. You must call (877) 731-6362 to arrange the lab order and be directed to a collection site.
The test requires a urine sample collected under strict chain-of-custody protocols at authorized collection sites.
Turnaround times vary based on the testing complexity and confirmatory steps. Contact AMH Nationwide at (877) 731-6362 for estimated timing.
Yes, every non-negative screen is reviewed by a certified Medical Review Officer to ensure accurate interpretation.
Testing is routed through one of five national lab networks: Quest Diagnostics, LabCorp, Omega Labs, United States Drug Testing Labs, or ExperTox.
The ExperTox Unknown Drug Panel is generally used for non-DOT testing. DOT-regulated tests require federally certified urine protocols under 49 CFR Part 40.
Ready to get started?
AMH Nationwide provides the lab order and arranges collection nationwide. Every non-negative result reviewed by a certified Medical Review Officer. Call (877) 731-6362 or contact us.